Loading...
XCNQAIML
Market cap9mUSD
Dec 24, Last price  
0.12CAD
1D
21.05%
1Q
35.29%
Jan 2017
-54.00%
IPO
-46.51%
Name

AI/ML Innovations Inc

Chart & Performance

D1W1MN
XCNQ:AIML chart
P/E
—
P/S
46.05
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
48.25%
Rev. gr., 5y
%
Revenues
295k
-36.73%
0000000000000000065,409466,014294,864
Net income
-3m
L+130.96%
-265,647-326,210-160,064-276,365-258,122-201,326-1,660,819-3,546,198-673,581-453,784-637,663-462,45188,090-124,101-166,696-235,909-2,725,885-3,173,286-1,422,266-3,284,865
CFO
-2m
L+158.64%
-180,911-159,936-145,381-196,111-107,434-263,587-195,321-2,368,543-298,071-104,813-109,035-14,699-21,966-37,100-7,148-126,912-931,347-3,023,574-634,276-1,640,504

Profile

AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML). It focuses on offering a patent-pending personal health monitoring and management system for caregivers, patients, and healthcare professionals to access and utilize data for enhance recovery outcomes and healthy living, as well as digital health software and wearable technologies. The company was formerly known as AIML Resources Inc. and changed its name to AI/ML Innovations Inc. in November 2020. AI/ML Innovations Inc. was incorporated in 2009 and is headquartered in Victoria, Canada.
URL
https://aiml-innovations.com/
IPO date
Feb 13, 2020
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑042023‑042022‑042021‑042020‑042019‑042018‑042017‑042016‑042015‑04
Income
Revenues
295
-36.73%
466
612.46%
65
 
Cost of revenue
1,569
1,953
3,377
Unusual Expense (Income)
NOPBT
(1,275)
(1,487)
(3,312)
NOPBT Margin
Operating Taxes
(125)
(70)
(337)
Tax Rate
NOPAT
(1,149)
(1,417)
(2,974)
Net income
(3,285)
130.96%
(1,422)
-55.18%
(3,173)
16.41%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,233
431
757
BB yield
-59.21%
-9.64%
-22.50%
Debt
Debt current
198
809
171
Long-term debt
51
183
Deferred revenue
Other long-term liabilities
Net debt
(19)
(393)
(1,232)
Cash flow
Cash from operating activities
(1,641)
(634)
(3,024)
CAPEX
Cash from investing activities
(326)
(211)
(1,143)
Cash from financing activities
2,163
374
1,275
FCF
(836)
(1,028)
(2,664)
Balance
Cash
217
15
525
Long term investments
1,239
1,060
Excess cash
202
1,230
1,582
Stockholders' equity
(1,210)
(280)
514
Invested Capital
198
809
236
ROIC
ROCE
125.91%
EV
Common stock shares outstanding
58,014
37,227
30,587
Price
0.07
-45.83%
0.12
9.09%
0.11
-84.51%
Market cap
3,771
-15.59%
4,467
32.77%
3,365
-71.56%
EV
3,713
4,041
1,537
EBITDA
(1,233)
(1,445)
(3,270)
EV/EBITDA
Interest
52
58
66
Interest/NOPBT